Profile data is unavailable for this security.
About the company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
- Revenue in USD (TTM)6.58bn
- Net income in USD-82.20m
- Incorporated2017
- Employees13.50k
- LocationAvantor IncBuilding One100 W Matsonford Rd Ste 200RADNOR 19087United StatesUSA
- Phone+1 (610) 386-1700
- Fax+1 (302) 636-5454
- Websitehttps://www.avantorsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lantheus Holdings Inc | 1.53bn | 167.68m | 4.45bn | 808.00 | 28.21 | 3.98 | 19.18 | 2.92 | 2.38 | 2.38 | 21.90 | 16.88 | 0.7055 | 8.67 | 4.48 | 1,888,531.00 | 7.75 | 9.87 | 10.50 | 11.33 | 62.23 | 60.44 | 10.99 | 12.86 | 2.49 | -- | 0.337 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| Stevanato Group SpA | 1.39bn | 167.22m | 4.61bn | 5.52k | 24.86 | 2.43 | 17.29 | 3.31 | 0.6127 | 0.6127 | 5.10 | 6.26 | 0.5058 | 2.95 | 2.65 | 252,140.50 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Teleflex Inc | 3.19bn | -327.85m | 4.68bn | 14.10k | -- | 1.22 | -- | 1.47 | -7.35 | -7.36 | 70.55 | 86.48 | 0.4154 | 2.05 | 6.00 | 226,240.30 | -4.27 | 4.58 | -4.69 | 5.01 | 53.67 | 54.77 | -10.28 | 11.38 | 1.53 | 6.78 | 0.4114 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| TransMedics Group Inc | 566.35m | 90.47m | 4.76bn | 728.00 | 58.51 | 13.39 | 41.00 | 8.40 | 2.38 | 2.41 | 14.48 | 10.40 | 0.6541 | 4.65 | 6.63 | 777,958.80 | 10.45 | -5.73 | 11.37 | -6.28 | 60.28 | 62.37 | 15.97 | -11.86 | 7.13 | 31.19 | 0.5903 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Merit Medical Systems Inc | 1.48bn | 118.43m | 4.87bn | 7.40k | 42.08 | 3.19 | 19.93 | 3.30 | 1.95 | 1.95 | 24.37 | 25.80 | 0.5898 | 2.39 | 7.38 | 199,611.90 | 4.73 | 3.49 | 5.17 | 3.93 | 48.47 | 45.37 | 8.02 | 5.65 | 2.86 | 14.41 | 0.324 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| iRhythm Holdings, Inc | 702.57m | -51.46m | 4.90bn | 2.00k | -- | 40.22 | -- | 6.98 | -1.62 | -1.62 | 22.11 | 3.78 | 0.7377 | 12.04 | 9.15 | 351,286.50 | -5.40 | -20.12 | -6.21 | -24.37 | 70.35 | 68.61 | -7.32 | -23.90 | 4.50 | -- | 0.8418 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.94bn | 12.30k | 109.77 | 1.59 | 30.32 | 1.82 | 0.2749 | 0.2749 | 16.10 | 18.96 | 0.4931 | 4.63 | 6.86 | -- | 0.8523 | -2.14 | 1.01 | -2.58 | 54.93 | 56.63 | 1.73 | -5.21 | 2.04 | 6.73 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 6.26bn | -- | -- | 13.07 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Bruker Corp | 3.44bn | -23.70m | 6.32bn | 11.40k | -- | 2.59 | 32.77 | 1.84 | -0.1562 | -0.1562 | 22.65 | 16.06 | 0.5481 | 1.44 | 5.23 | 301,763.80 | -0.3554 | 6.80 | -0.4523 | 9.20 | 48.00 | 50.00 | -0.6485 | 9.66 | 0.8877 | 9.34 | 0.4462 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Glaukos Corp | 469.82m | -87.61m | 6.49bn | 995.00 | -- | 8.43 | -- | 13.82 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Masimo Corp | 1.72bn | -203.80m | 7.20bn | 3.60k | -- | 8.79 | -- | 4.20 | -3.83 | -10.61 | 31.70 | 15.25 | 0.6993 | 1.70 | 5.09 | 476,416.70 | -8.31 | 3.29 | -10.46 | 3.99 | 54.96 | 53.94 | -11.88 | 4.56 | 1.92 | 5.88 | 0.4084 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
| Avantor Inc | 6.58bn | -82.20m | 7.61bn | 13.50k | -- | 1.37 | 23.37 | 1.16 | -0.1203 | -0.1203 | 9.64 | 8.17 | 0.5364 | 5.58 | 6.07 | 487,051.80 | -0.6706 | 3.94 | -0.7693 | 4.48 | 33.13 | 33.76 | -1.25 | 6.87 | 0.9639 | 3.95 | 0.4092 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
| Repligen Corp | 707.89m | 1.74m | 8.05bn | 1.78k | 5,555.73 | 3.87 | 96.98 | 11.38 | 0.0258 | 0.0258 | 12.55 | 37.01 | 0.246 | 2.00 | 5.09 | 398,138.30 | 0.0604 | 3.28 | 0.063 | 3.70 | 51.59 | 54.24 | 0.2455 | 12.37 | 7.14 | -- | 0.2052 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
| Bio Rad Laboratories Inc | 2.56bn | -675.90m | 8.07bn | 7.70k | -- | 1.20 | -- | 3.15 | -24.30 | -24.30 | 92.91 | 249.77 | 0.252 | 1.53 | 5.52 | 332,139.60 | -6.66 | 3.00 | -7.01 | 3.15 | 52.42 | 55.37 | -26.43 | 14.51 | 3.94 | 0.2476 | 0.1515 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Henry Schein Inc | 12.94bn | 391.00m | 9.54bn | 25.00k | 25.60 | 2.86 | 13.51 | 0.7372 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
Data as of Feb 11 2026. Currency figures normalised to Avantor Inc's reporting currency: US Dollar USD
56.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dodge & Coxas of 30 Sep 2025 | 117.75m | 17.27% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 59.71m | 8.76% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 53.79m | 7.89% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 30 Sep 2025 | 34.55m | 5.07% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 32.93m | 4.83% |
| Greenhaven Associates, Inc.as of 31 Dec 2025 | 20.50m | 3.01% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 20.37m | 2.99% |
| Engine Capital Management LPas of 30 Sep 2025 | 19.72m | 2.89% |
| Clarkston Capital Partners LLCas of 30 Sep 2025 | 15.02m | 2.20% |
| The London Company of Virginia LLCas of 30 Sep 2025 | 12.79m | 1.88% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
